4540
TSUMURA & CO.
ツムラ
- Industry
- Pharmaceutical
- Market
- Prime
- Accounting standards
- Japanese GAAP
- Consolidation basis
- Consolidated
Key metrics
Revenue(million JPY)
Mar 2022
129,546
Mar 2023
140,043
Mar 2024
150,845
Mar 2025
181,093
Mar 2026
192,615
Operating profit(million JPY)
Mar 2022
22,376
Mar 2023
20,916
Mar 2024
20,017
Mar 2025
40,125
Mar 2026
35,219
Operating profit margin(%)
Mar 2022
17.27
Mar 2023
14.94
Mar 2024
13.27
Mar 2025
22.16
Mar 2026
18.28
Profit before tax(million JPY)
Mar 2022
25,563
Mar 2023
23,018
Mar 2024
23,736
Mar 2025
45,559
Mar 2026
41,036
Profit(million JPY)
Mar 2022
18,836
Mar 2023
16,482
Mar 2024
16,707
Mar 2025
32,428
Mar 2026
28,117
Total assets(million JPY)
Mar 2022
350,981
Mar 2023
396,813
Mar 2024
428,254
Mar 2025
464,380
Mar 2026
592,766
Cash and cash equivalents(million JPY)
Mar 2022
67,536
Mar 2023
94,730
Mar 2024
78,034
Mar 2025
73,135
Mar 2026
78,261
Cash flows from operating activities(million JPY)
Mar 2022
21,314
Mar 2023
16,452
Mar 2024
5,608
Mar 2025
33,823
Mar 2026
24,718
Cash flows from investing activities(million JPY)
Mar 2022
-9,111
Mar 2023
-15,493
Mar 2024
-19,351
Mar 2025
-24,974
Mar 2026
-50,309
Cash flows from financing activities(million JPY)
Mar 2022
-8,181
Mar 2023
24,423
Mar 2024
-4,417
Mar 2025
-19,871
Mar 2026
32,603
Return on equity(%)
Mar 2022
8.23
Mar 2023
6.7
Mar 2024
6.39
Mar 2025
11.35
Mar 2026
9.04
Equity ratio(%)
Mar 2022
68.3
Mar 2023
63.5
Mar 2024
63.2
Mar 2025
64.7
Mar 2026
54.3
Earnings per share(JPY per share)
Mar 2022
246.21
Mar 2023
215.63
Mar 2024
219.83
Mar 2025
427.15
Mar 2026
376.28
Net assets per share(JPY per share)
Mar 2022
3,133.97
Mar 2023
3,299.42
Mar 2024
3,566.54
Mar 2025
3,968.05
Mar 2026
4,315.88
Dividend per share(JPY per share)
Mar 2022
64
Mar 2023
64
Mar 2024
85
Mar 2025
136
Mar 2026
147
Payout ratio(%)
Mar 2022
25.99
Mar 2023
29.68
Mar 2024
38.67
Mar 2025
31.84
Mar 2026
39.07
Disclaimer
The financial information and metrics on this page are based on publicly available filings and other public sources. We do not guarantee their accuracy, completeness, or timeliness.
The information on this page is provided for reference purposes only and does not constitute a recommendation to buy or sell any security. Investment decisions should be made at your own responsibility.